Effect and mechanism of melatonin's action on the proliferation of human umbilical vein endothelial cells
- 14 September 2006
- journal article
- Published by Wiley in Journal of Pineal Research
- Vol. 41 (4), 358-362
- https://doi.org/10.1111/j.1600-079x.2006.00375.x
Abstract
Melatonin is the major secretory product of the pineal gland and is considered an important natural oncostatic agent. The anticancer activity of melatonin is due to its immunomodulatory, anti-proliferative and antioxidative effects. At present there are no direct data available as to melatonin's possible influence on angiogenesis, which is a major biological mechanism responsible for tumor growth and dissemination. The current study investigated the influence of melatonin on angiogenesis. Human umbilical vein endothelial cells (HUVECs) were cultured, identified, and purified. Cell growth and viability, DNA fragmentation and cell cycle analyses were determined. To elucidate the mechanism of action of melatonin, Western blot analyses for P53, Bax and Bcl-2 expression were carried out. The results demonstrate the anti-proliferative and apoptosis-inducing effects of melatonin; these changes were associated with cell cycle arrest, upregulation of P53 and Bax and downregulation of Bcl-2. Taken together, our data showed that melatonin in high concentrations markedly reduces HUVECs proliferation, induces cellular apoptosis, and modulates cell cycle length. P53 and Bax/Bcl-2 expression changes may be involved in these actions of melatonin.Keywords
This publication has 22 references indexed in Scilit:
- Melatonin–estrogen interactions in breast cancerJournal of Pineal Research, 2005
- Melatonin and cell death: differential actions on apoptosis in normal and cancer cellsCellular and Molecular Life Sciences, 2003
- Endothelin-1: a multifunctional molecule in cancerBritish Journal of Cancer, 2003
- Melatonin and prostate cancer cell proliferation: Interplay with castration, epidermal growth factor, and androgen sensitivityThe Prostate, 2002
- Melatonin as a Chronobiotic / Anticancer Agent: Cellular, Biochemical, and Molecular Mechanisms of Action and their Implications for Circadian-Based Cancer TherapyCurrent Topics in Medicinal Chemistry, 2002
- Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivoOncogene, 2001
- Isoform Expression of CD44 Adhesion Molecules, Bcl-2, p53 and Ki-67 Proteins in Lung CancerTumor Biology, 2001
- Angiogenesis in cancer and other diseasesNature, 2000
- Estrogen receptor transactivation in MCF-7 breast cancer cells by melatonin and growth factorsMolecular and Cellular Endocrinology, 1998
- Molecular and biological properties of the vascular endothelial growth factor family of proteinsEndocrine Reviews, 1992